Dallas Fort Worth Injury Lawyer Blog

February 28, 2010

Plaintiffs in Personal Injury Suit Say Exxon ‘Reckless’ With Worker Safety

Exxon Mobil Corp., showed “reckless and reprehensible” behavior by failing to protect workers from dangerous radioactive material in used oil-drilling pipes, a lawyer for 16 men told a Louisiana jury.

“Exxon recklessly put profits above workers’ safety,” Frank Buck told jurors in Gretna, Louisiana, in his closing argument at the end of a five-week trial.

Buck told jurors they should award more than $17 million to a group of 16 pipe workers who sued Exxon, claiming they were exposed to high levels of radium in the residue, or “scale,” that built up inside the pipes and now fear they may develop cancer.

Read full story here at the Houston Chronicle.

February 27, 2010

Judge: Lejeune Resident Can Move Ahead With Injury Claim

by Dr. Shezad Malik

For what appears to be the first time, a former resident of Camp Lejeune, N.C., has been permitted to move ahead with a claim against the Marine Corps for years of water contamination that she says led to the development of her non-Hodgkin’s lymphoma.

The U.S. Department of the Navy, which includes the Marines, this week lost its bid to dismiss the case of Laura J. Jones of Iowa, who lived at Camp Lejeune from 1980 to 1983 as the spouse of a Marine officer.

In 2005, more than two decades after she left North Carolina, Jones was diagnosed with non-Hodgkin’s lymphoma.

February 26, 2010

Toyota Owners Took Concerns to Dealership Before Fatal Southlake Crash

by Dr. Shezad Malik

Monty and Linda Hardy had taken their 2008 Toyota Avalon to a Grapevine dealership “several times” with complaints about uncommanded acceleration but were told there was nothing wrong, their attorney says.

On the day after Christmas, Monty Hardy was driving the Toyota in Southlake when it sped through a T-intersection, barreled through a steel fence, struck a tree and landed upside down in an icy pond. He and all three passengers in the car were killed.

Read full story here at Dallas Morning News

February 26, 2010

Glaxo Backs Avandia’s Safety Says That US Report Biased

by Dr. Shezad Malik

GlaxoSmithKline Plc rejected allegations that it concealed safety information about its diabetes drug Avandia or acted inappropriately in marketing it, saying a U.S. Senate staff report was inaccurate and incomplete.

The company diligently studied the drug’s safety and effectiveness, and communicated its findings to governments, regulators, scientists and doctors, London-based Glaxo said in a statement.

Read the full Bloomberg story here.

February 25, 2010

Woman Gets $23.4M for Personal Injury Ford Crash

by Dr. Shezad Malik

A jury has awarded a woman $23.4 million in a civil judgment against Ford Motor Co. for a 2007 freeway accident that left her a quadriplegic.

Cynthia Castillo lost control of her 1997 Ford Explorer when the tread separated from her left-rear tire as she drove on the freeway.

Her attorney, Brian Brandt, said the SUV veered off the freeway and rolled three times down an embankment, leaving her legs and most of her body paralyzed. Flaws in the vehicle’s design caused it to lose control when the tire tread separates, Brandt said.

Read full story here.

February 24, 2010

Idaho Springs Man Awarded $18.5 M in DUI Case

by Dr. Shezad Malik

An Idaho Springs man was awarded $18.5 million for catastrophic injuries he suffered when a driver drunk on alcohol and high on marijuana left a mountain road and slammed into him as he was changing the oil on his wife’s car in their driveway.

Clear Creek District Court Judge Granger assessed the award against the driver, Kevin Ruszkowski, 24; the owner of the Jeep, Randall Guy; and Guy’s son, Justin Guy, 20, who had allowed Ruszkowski to drive the vehicle.

Paul Savage, 46, who was injured, was head waiter at the Alpenglow Stube at Keystone at the time.

Ruszkowski had no license because his driving privileges had either been suspended or revoked for prior driving misconduct.

Read more: http://www.denverpost.com/news/ci_14419648#ixzz0gN2hsQw2

February 23, 2010

Federal Subpoenas Hit Toyota on the Eve of Hearing

by Dr. Shezad Malik

The pressure on Toyota Motor Corp. intensified as the company disclosed subpoenas from a federal grand jury and the Securities and Exchange Commission related to sudden acceleration in its cars, while the leaders of a congressional panel accused Toyota of misleading the public about safety problems.

The House Energy and Commerce Committee, in an 11-page letter, previewed issues its members likely will raise at a hearing Tuesday. The letter criticized Toyota for resisting the possibility that electronic defects could be responsible for the reports of unintended acceleration.

Read full story here at the WSJ.

February 23, 2010

FDA Faces More Pressure to Pull Avandia Diabetes Drug

by Dr. Shezad Malik

The Food and Drug Administration, under fire from a new Senate report questioning the safety of GlaxoSmithKline PLC’s diabetes drug Avandia, told doctors that patients taking the medicine should stay on it unless their doctors say otherwise.

Rep. Rosa DeLauro (D., Conn.), the chairwoman of the House appropriations panel that controls the FDA’s budget, said: “I strongly urge the FDA to remove Avandia from the market until a truly independent, science-based advisory panel can evaluate the safety and effectiveness of the drug.”

Read full article here at the Wall Street Journal.

February 23, 2010

Texas Woman Dies After Walking Into Train in Dallas

by Dr. Shezad Malik

A pedestrian wearing a hooded jacket has been killed by a commuter train in Dallas.

The woman walked into a Trinity Railway Express train, which links Dallas and Fort Worth and carries about 10,000 passengers daily, during afternoon rush hour Monday.

Read full story here at the Fort Worth Star Telegram

February 22, 2010

Heart Attack and Heart Failure Side Effects of Avandia Diabetes Drug

by Dr. Shezad Malik

Three years ago, Dr.Nissen, a cardiologist at the Cleveland Clinic, conducted a landmark study that suggested that the best-selling diabetes drug Avandia raised the risk of heart attacks. The study led to a Congressional inquiry, stringent safety warnings, a sharp drop in the drug’s sales of GlaxoSmithKline, Avandia’s maker.

The battle between Dr. Nissen and GlaxoSmithKline was waged from afar in news releases and published papers. But on May 10, 2007, 11 days before Dr. Nissen’s study was published in The New England Journal of Medicine, he and four company executives met face to face in a private meeting whose details have not been disclosed until now.

Read the full article here at the New York Times.